dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing From New Investors
dMed-Clinipace, the global full-service Clinical Contract Research Organization (CRO), announced the successful completion of a US$50 million Series C+ financing with participation from a group of new, leading international healthcare investors.
